Roopa Sethi

573 total citations
31 papers, 432 citations indexed

About

Roopa Sethi is a scholar working on Public Health, Environmental and Occupational Health, Anesthesiology and Pain Medicine and Toxicology. According to data from OpenAlex, Roopa Sethi has authored 31 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Public Health, Environmental and Occupational Health, 11 papers in Anesthesiology and Pain Medicine and 8 papers in Toxicology. Recurrent topics in Roopa Sethi's work include Opioid Use Disorder Treatment (20 papers), Pain Management and Opioid Use (8 papers) and Forensic Toxicology and Drug Analysis (8 papers). Roopa Sethi is often cited by papers focused on Opioid Use Disorder Treatment (20 papers), Pain Management and Opioid Use (8 papers) and Forensic Toxicology and Drug Analysis (8 papers). Roopa Sethi collaborates with scholars based in United States. Roopa Sethi's co-authors include S. D. Deodhar, R.C. Srimal, Ann M. Manzardo, Anita S. Kablinger, Jonna G. Detweiler and Mark B. Detweiler and has published in prestigious journals such as Journal of Addictive Diseases, Substance Abuse and Journal of Aging & Social Policy.

In The Last Decade

Roopa Sethi

28 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roopa Sethi United States	5	222	121	115	73	40	31	432
Zahra Ayati Iran	14	62 0.3×	87 0.7×	162 1.4×	70 1.0×	60 1.5×	22	649
Krishnakumar IM India	13	192 0.9×	57 0.5×	111 1.0×	46 0.6×	10 0.3×	24	458
Areg Hovhannisyan Armenia	11	149 0.7×	153 1.3×	335 2.9×	161 2.2×	16 0.4×	12	697
Mojdeh Mohammadi Iran	15	47 0.2×	43 0.4×	109 0.9×	48 0.7×	97 2.4×	61	569
Bijan Helli Iran	10	39 0.2×	30 0.2×	74 0.6×	39 0.5×	31 0.8×	24	370
Sandra Sonego Australia	8	57 0.3×	126 1.0×	141 1.2×	35 0.5×	24 0.6×	9	570
Bruno Ambrósio da Rocha Brazil	12	42 0.2×	51 0.4×	81 0.7×	127 1.7×	13 0.3×	27	399
Ali Saeedi‐Boroujeni Iran	13	34 0.2×	28 0.2×	216 1.9×	43 0.6×	31 0.8×	32	563
Ashok Vaidya India	10	52 0.2×	59 0.5×	86 0.7×	92 1.3×	14 0.3×	37	451
Rafe Bundy United Kingdom	7	66 0.3×	59 0.5×	61 0.5×	39 0.5×	83 2.1×	8	429

Countries citing papers authored by Roopa Sethi

Since Specialization

Citations

This map shows the geographic impact of Roopa Sethi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roopa Sethi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roopa Sethi more than expected).

Fields of papers citing papers by Roopa Sethi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roopa Sethi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roopa Sethi. The network helps show where Roopa Sethi may publish in the future.

Co-authorship network of co-authors of Roopa Sethi

This figure shows the co-authorship network connecting the top 25 collaborators of Roopa Sethi. A scholar is included among the top collaborators of Roopa Sethi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roopa Sethi. Roopa Sethi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sethi, Roopa, et al.. (2024). Buprenorphine: two adolescent case reports of bridging the transmucosal form to the extended-release subcutaneous injectable form. Journal of Addictive Diseases. 42(4). 426–431. 1 indexed citations

Sethi, Roopa, et al.. (2024). Tianeptine as an opiate replacement in a patient on methadone treatment: A case report. Journal of Opioid Management. 20(1). 87–91. 2 indexed citations

Sethi, Roopa, et al.. (2024). The Effectiveness of Buprenorphine Transdermal Patch and Low Dose Sublingual Buprenorphine Induction to Transition to Long-Acting Subcutaneous Buprenorphine Injection in Opioid Use Disorder in Inpatient Setting. Kansas Journal of Medicine. 17(1). 20–21.

Sethi, Roopa, et al.. (2023). Illicit Non-Pharmaceutical Fentanyl and its Analogs: A Short Review of Literature. Kansas Journal of Medicine. 16(1). 25–27. 4 indexed citations

Sethi, Roopa, et al.. (2023). The Growing Epidemic of Opioid Use Disorder in the Elderly and Its Treatment. The Primary Care Companion For CNS Disorders. 25(1). 14 indexed citations

Sethi, Roopa, et al.. (2023). The Appearance of Xylazine in the United States as a Fentanyl Adulterant. The Primary Care Companion For CNS Disorders. 25(6). 4 indexed citations

Sethi, Roopa, et al.. (2023). Xylazine Use in Pregnancy: The Effects of the Fentanyl Adulterant Xylazine on Pregnant Patients and the Developing Fetus. Kansas Journal of Medicine. 16(3). 277–279. 3 indexed citations

Sethi, Roopa, et al.. (2022). Role of Buprenorphine in an Adolescent with Opioid Abuse. Kansas Journal of Medicine. 15(2). 197–197. 2 indexed citations

Sethi, Roopa, et al.. (2022). Outpatient Rapid Microinduction of Sublingual Buprenorphine in 3 Days From Methadone for Opioid Use Disorder. The Primary Care Companion For CNS Disorders. 24(6). 2 indexed citations

10.

Sethi, Roopa, et al.. (2021). Rapid microinduction of sublingual buprenorphine from methadone in an outpatient setting: “A case series”. Journal of Opioid Management. 17(7). 167–170. 3 indexed citations

11.

Sethi, Roopa, et al.. (2021). Phenibut Dependence and Withdrawal. The Primary Care Companion For CNS Disorders. 23(1). 7 indexed citations

12.

Sethi, Roopa, et al.. (2020). Tapentadol. The Primary Care Companion For CNS Disorders. 22(1).

13.

Sethi, Roopa, et al.. (2020). Kratom (Mitragyna speciosa). The Primary Care Companion For CNS Disorders. 22(1). 20 indexed citations

14.

Sethi, Roopa, et al.. (2019). Should Long-Acting Depot Intramuscular Naltrexone Be Prescribed Every 3 Weeks for Alcohol Use Disorder?. The Primary Care Companion For CNS Disorders. 21(3). 1 indexed citations

15.

Sethi, Roopa, et al.. (2016). Will Adding Methadone to Controlled Substance Monitoring Programs Help Psychiatrists Prevent Prescription Drug Overdoses?. The Primary Care Companion For CNS Disorders. 18(2). 1 indexed citations

16.

Sethi, Roopa, et al.. (2013). Are "Bath Salts" on Your Differential List? A Case Report of Delirium and Agitation After Use of Illicit Bath Salts. The Primary Care Companion For CNS Disorders. 15(2). 1 indexed citations

17.

Sethi, Roopa, et al.. (2013). “K2/Spice”. The Primary Care Companion For CNS Disorders. 15(2). 2 indexed citations

18.

Sethi, Roopa, et al.. (2012). Hypothermia Secondary to Ziprasidone Use in a Man With Schizophrenia. The Primary Care Companion For CNS Disorders. 14(4). 2 indexed citations

19.

Sethi, Roopa, et al.. (2012). Serotonin Syndrome in a Sertraline-Treated Man Taking NyQuil Containing Dextromethorphan for Cold. The Primary Care Companion For CNS Disorders. 14(6). 4 indexed citations

20.

Sethi, Roopa, et al.. (2012). Doxazosin for the Treatment of Nightmares. The Primary Care Companion For CNS Disorders. 14(5). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact